An osteopathic physician is not subject to disciplinary action solely for:
1. Prescribing or administering to a patient under his or her care:
(a) Amygdalin (laetrile), if the patient has consented to the use of the substance.
(b) Procaine hydrochloride with preservatives and stabilizers (Gerovital H3).
(c) A controlled substance which is listed in schedule II, III, IV or V by the State Board of Pharmacy pursuant to NRS 453.146, if the controlled substance is lawfully prescribed or administered for the treatment of intractable pain in accordance with the provisions of NRS 639.23507 and 639.2391 to 639.23916, inclusive, and any regulations adopted by the State Board of Pharmacy pursuant thereto and the accepted standards for the practice of osteopathic medicine.
2. Engaging in any activity in accordance with the provisions of chapter 678C of NRS.
(Added to NRS by 1977, 1647; A 1983, 337; 1995, 1734; 2003, 1435; 2017, 4423; 2019, 3891, effective July 1, 2020)